Literature DB >> 33447941

Intelligent automated drug administration and therapy: future of healthcare.

Richa Sharma1, Dhirendra Singh2, Prerna Gaur3, Deepak Joshi4,5.   

Abstract

In the twenty-first century, the collaboration of control engineering and the healthcare sector has matured to some extent; however, the future will have promising opportunities, vast applications, and some challenges. Due to advancements in processing speed, the closed-loop administration of drugs has gained popularity for critically ill patients in intensive care units and routine life such as personalized drug delivery or implantable therapeutic devices. For developing a closed-loop drug delivery system, the control system works with a group of technologies like sensors, micromachining, wireless technologies, and pharmaceuticals. Recently, the integration of artificial intelligence techniques such as fuzzy logic, neural network, and reinforcement learning with the closed-loop drug delivery systems has brought their applications closer to fully intelligent automatic healthcare systems. This review's main objectives are to discuss the current developments, possibilities, and future visions in closed-loop drug delivery systems, for providing treatment to patients suffering from chronic diseases. It summarizes the present insight of closed-loop drug delivery/therapy for diabetes, gastrointestinal tract disease, cancer, anesthesia administration, cardiac ailments, and neurological disorders, from a perspective to show the research in the area of control theory.
© 2021. Controlled Release Society.

Entities:  

Keywords:  Biological systems; Cancer treatment; Cardiac ailments; Closed-loop control; Control system; Drug delivery; GI tract; Insulin therapy; Neurological disorders

Mesh:

Substances:

Year:  2021        PMID: 33447941     DOI: 10.1007/s13346-020-00876-4

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  103 in total

1.  Development of a multi-parametric model predictive control algorithm for insulin delivery in type 1 diabetes mellitus using clinical parameters.

Authors:  M W Percival; Y Wang; B Grosman; E Dassau; H Zisser; L Jovanovič; F J Doyle
Journal:  J Process Control       Date:  2011-03-01       Impact factor: 3.666

Review 2.  Closed-loop insulin delivery-the path to physiological glucose control.

Authors:  G M Steil; A E Panteleon; K Rebrin
Journal:  Adv Drug Deliv Rev       Date:  2004-02-10       Impact factor: 15.470

Review 3.  MEMS: Enabled Drug Delivery Systems.

Authors:  Angelica Cobo; Roya Sheybani; Ellis Meng
Journal:  Adv Healthc Mater       Date:  2015-02-20       Impact factor: 9.933

Review 4.  E-drug delivery: a futuristic approach.

Authors:  Khushwant S Yadav; Sonali Kapse-Mistry; G J Peters; Y C Mayur
Journal:  Drug Discov Today       Date:  2019-02-19       Impact factor: 7.851

Review 5.  Drug delivery systems for programmed and on-demand release.

Authors:  Pooya Davoodi; Lai Yeng Lee; Qingxing Xu; Vishnu Sunil; Yajuan Sun; Siowling Soh; Chi-Hwa Wang
Journal:  Adv Drug Deliv Rev       Date:  2018-07-06       Impact factor: 15.470

6.  Electronically enabled drug-delivery devices: are they part of the future?

Authors:  Andy Fry
Journal:  Ther Deliv       Date:  2012-07

Review 7.  A review of magnet systems for targeted drug delivery.

Authors:  Ya-Li Liu; Da Chen; Peng Shang; Da-Chuan Yin
Journal:  J Control Release       Date:  2019-04-01       Impact factor: 9.776

8.  Closed-loop regulation of a physiological parameter by an IPFM/SDC (integral pulse frequency modulated/Smith delay compensator) controller.

Authors:  E A Woodruff; R B Northrop
Journal:  IEEE Trans Biomed Eng       Date:  1987-08       Impact factor: 4.538

Review 9.  Using skin for drug delivery and diagnosis in the critically ill.

Authors:  Xin Liu; Peter Kruger; Howard Maibach; Paul B Colditz; Michael S Roberts
Journal:  Adv Drug Deliv Rev       Date:  2014-10-13       Impact factor: 15.470

10.  Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis.

Authors:  Revital Nimri; Ido Muller; Eran Atlas; Shahar Miller; Olga Kordonouri; Natasa Bratina; Christiana Tsioli; Magdalena A Stefanija; Thomas Danne; Tadej Battelino; Moshe Phillip
Journal:  Pediatr Diabetes       Date:  2013-08-15       Impact factor: 4.866

View more
  2 in total

Review 1.  Enhancing Clinical Translation of Cancer Using Nanoinformatics.

Authors:  Madjid Soltani; Farshad Moradi Kashkooli; Mohammad Souri; Samaneh Zare Harofte; Tina Harati; Atefeh Khadem; Mohammad Haeri Pour; Kaamran Raahemifar
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

Review 2.  Recent Advances in Wearable Sensing Technologies.

Authors:  Alfredo J Perez; Sherali Zeadally
Journal:  Sensors (Basel)       Date:  2021-10-14       Impact factor: 3.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.